hVIVO (LON:HVO) Shares Down 6.8% – Here’s Why

hVIVO plc (LON:HVO) was down 6.8% during trading on Thursday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares were traded during mid-day trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).

hVIVO Stock Down 6.8 %

The stock has a market cap of £129.95 million, a price-to-earnings ratio of 636.67 and a beta of 0.97. The firm has a 50 day simple moving average of GBX 23.39 and a two-hundred day simple moving average of GBX 26.71. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.